Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older

(2013) Lisa A. Jackson et al.   VACCINE

Variation between Populations in the Innate Immune Response to Vaccine Adjuvants

(2013) Tobias R. Kollmann   Frontiers in Immunology

Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells

(2012) Elizabeth A. Clutterbuck et al.   JOURNAL OF INFECTIOUS DISEASES

Review on the immunogenicity and safety of PCV-13 in infants and toddlers

(2011) Marta C Nunes et al.   Expert Review of Vaccines

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A

(2011) David Cooper et al.   VACCINE

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

(2011) T.F. Schwarz et al.   VACCINE

Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan

(2009) N. CHIBA et al.   EPIDEMIOLOGY AND INFECTION

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

A novel method for rapid detection of Streptococcus pneumoniae antigen in sputum and its application in adult respiratory tract infections

(2008) N. Ehara et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Sexual dimorphism of humoral immunity with human vaccines

(2008) Ian Francis Cook   VACCINE